Drugs / FluMist/B/Yamagata
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT00860067 Comparator | Mar → May 2009 | — | MedImmune LLC | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FluMist/B/Yamagata | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00860067 ↗ |
| Modality | Vaccine | “FluMist/B/Yamagata (trivalent influenza vaccine)” NCT00860067 ↗ |